US2006293236A1PendingUtilityA1

Injectable Osteogenic Formula and Method of Using Same

51
Individually held — no corporate assignee on recordPriority: Jun 23, 2005Filed: Jun 23, 2006Published: Dec 28, 2006
Est. expiryJun 23, 2025(expired)· nominal 20-yr term from priority
Inventors:Albert G. PrescottPaul OdgrenJulia Marks
A61K 31/557A61K 31/728A61K 38/16A61K 9/0019A61K 47/36A61K 31/5575
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Formulations and methods for growing bone in a site specific location using an osteogenic molecule such as a prostaglandin, and a delivery vehicle which is preferably a polymer matrix.

Claims

exact text as granted — not AI-modified
1 . An osteogenic formulation, comprising: 
 an osteogenic compound; and    a delivery vehicle.    
   
   
       2 . The osteogenic formulation of  claim 1 , wherein the compound comprises prostaglandin (PGE).  
   
   
       3 . The osteogenic formulation of  claim 2  in which the compound is PGE1.  
   
   
       4 . The osteogenic formulation of  claim 2  in which the compound is PGE2.  
   
   
       5 . The osteogenic formulation of  claim 1 , wherein the delivery vehicle comprises a biodegradable matrix.  
   
   
       6 . The osteogenic formulation of  claim 5 , wherein the biodegradable matrix comprises a polymer.  
   
   
       7 . The osteogenic formulation of  claim 6 , wherein the polymer comprises hyaluronic acid or a salt thereof.  
   
   
       8 . The osteogenic formulation of  claim 6 , wherein the polymer comprises a poly-glutamic acid.  
   
   
       9 . An osteogenic formulation, comprising: 
 prostaglandin (PGE) osteogenic compound; and    a biodegradable polymer matrix delivery vehicle for the PGE.    
   
   
       10 . The osteogenic formulation of  claim 9 , wherein the polymer comprises hyaluronic acid or a salt thereof.  
   
   
       11 . The osteogenic formulation of  claim 9 , wherein the polymer comprises a poly-glutamic acid.  
   
   
       12 . A method of employing an osteogenic compound, comprising: 
 providing prostaglandin (PGE) osteogenic compound;    providing a biodegradable polymer matrix delivery vehicle for the PGE;    mixing the PGE and the delivery vehicle; and    delivering the mixture to a site.    
   
   
       13 . The method of  claim 12  in which the PGE comprises PGE1.  
   
   
       14 . The method of  claim 12  in which the PGE comprises PGE2.  
   
   
       15 . The method of  claim 12  in which the polymer comprises hyaluronic acid or a salt thereof.  
   
   
       16 . The method of  claim 12  in which the polymer comprises a poly-glutamic acid.  
   
   
       17 . The method of  claim 12  in which delivery is accomplished with a syringe.  
   
   
       18 . A method of employing an osteogenic compound, comprising: 
 providing prostaglandin (PGE) osteogenic compound;    providing a biodegradable polymer matrix delivery vehicle for the PGE comprising hyaluronic acid or a salt thereof;    mixing the PGE and the delivery vehicle; and    delivering the mixture to a site with a syringe.

Join the waitlist — get patent alerts

Track US2006293236A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.